Clinical Trial Update: Study of Magrolimab Given Together With FOLFIRI/Bevacizumab (BEV) in Participants With Previously Treated Advanced Inoperable Metastatic Colorectal Cancer (mCRC) [Phase 2]

View source ↗

Summary

Phase 2 study of magrolimab with FOLFIRI and bevacizumab in previously treated advanced, inoperable metastatic colorectal cancer was terminated; results were po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Bevacizumab (bevacizumab)
• Irinotecan (Irinotecan)
• Leucovorin (folinic acid)
• Magrolimab (magrolimab)

Snippet

Sponsor: Gilead Sciences | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: TERMINATED | Results posted: 2025-07-01